Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Castle Biosciences, Inc. (CSTL) had Cash Flow from Investing Activities of $-60.37M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$344.23M |
|
$-24.16M |
|
$71.03M |
|
$273.20M |
|
$387.04M |
|
$-42.81M |
|
$13.30M |
|
$-29.51M |
|
$-29.51M |
|
$-24.16M |
|
$-24.16M |
|
$-24.16M |
|
$-24.16M |
|
$-42.81M |
|
$-6.26M |
|
28.99M |
|
28.99M |
|
$-0.83 |
|
$-0.83 |
|
| Balance Sheet Financials | |
$361.10M |
|
$97.44M |
|
$217.46M |
|
$578.56M |
|
$68.68M |
|
$9.95M |
|
$39.01M |
|
$107.68M |
|
$470.87M |
|
$371.30M |
|
$470.87M |
|
29.69M |
|
| Cash Flow Statement Financials | |
$64.35M |
|
|
Cash Flow from Investing Activities |
$-60.37M |
$-6.96M |
|
$119.71M |
|
$116.73M |
|
$-2.98M |
|
$45.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.26 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
79.37% |
|
-12.44% |
|
-12.44% |
|
-1.82% |
|
-8.57% |
|
-7.02% |
|
$28.37M |
|
-- |
|
-- |
|
-- |
|
0.59 |
|
6.93 |
|
7.93 |
|
46.00 |
|
-5.13% |
|
-6.51% |
|
-4.18% |
|
-5.02% |
|
$15.86 |
|
$0.98 |
|
$2.22 |
|